Vaginal microbiota and sexually transmitted infections that may influence transmission of Cell-Associated HIV

Journal of Infectious Diseases

Volumn 210, Issue , 2014, Pages S616-S621

  Cone, Richard A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell Associated HIV; Inflammatory cytokines.; Lactic acid; Polymicrobial microbiota

Indexed keywords

LACTIC ACID;

COMPLICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTOBACILLUS; LEUKOCYTE; MALE; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY; SEXUALLY TRANSMITTED DISEASE; TRANSMISSION; VAGINA; VAGINA DISEASE; VIROLOGY;

FEMALE; HIV INFECTIONS; HUMANS; LACTIC ACID; LACTOBACILLUS; LEUKOCYTES; MALE; MICROBIOTA; SEXUALLY TRANSMITTED DISEASES; VAGINA; VAGINAL DISEASES;

EID: 84925224010     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu459     Document Type: Article

References (59)

1. Barreto-de-Souza V, Arakelyan A, Margolis L, et al. HIV-1 Vaginal transmission: cell-free or cell-Associated virus? Am J Reprod Immunol 2014; 71:589-99.
2. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
4. Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr 2000; 24:48-56.
5. Gray RH, Wawer MJ, Sewankambo N, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:1780.
6. Cohen CR, Lingappa JR, Baeten JM, et al. Bacterial vaginosis associated with increased risk of female-To-male HIV-1 transmission: A prospective cohort analysis among African couples. PLoS Med 2012; 9:e1001251.
7. Doncel GF, Anderson S, Zalenskaya I. Role of semen in modulating the female genital tract microenvironment-implications for HIV transmission. Am J Reprod Immunol 2014; 71:564-74.
8. Nardis C, Mosca L, Mastromarino P. Vaginal microbiota and viral sexually transmitted diseases. Ann Ig 2013; 25:443-56.
9. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: systematic review, meta-Analysis and implications for HIV prevention. Int J Epidemiol 2010; 39:1048-63.
10. Patton DL, Thwin SS, Meier A, et al. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000; 183:967-73.
11. Averette HE, Weinstein GD, Frost P. Autoradiographic analysis of cell proliferation kinetics in human genital tissues. I. Normal cervix and vagina. Am J Obstet Gynecol 1970; 108:8-17.
12. Döderlein A. Uber Scheidensekrete und Scheidenkeime [Vaginal secretions and vaginal microbes]. Die Verhandlungen der deutschen Gesellschaft för Gynäkologie 1892; 4:35-50.
13. Pybus V, Onderdonk AB. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis. Microbes Infect 1999; 1:285-92.
14. Boskey ER, Cone RA, Whaley KJ, et al. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod 2001; 16:1809-13.
15. Boskey ER, Telsch KM, Whaley KJ, et al. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 1999; 67:5170-5.
16. OHanlon DE, Moench TR, Cone RA. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS One 2013; 8:e80074.
17. Brotman RM, Bradford LL, Conrad M, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2014; 21:450-8.
18. Song YL, Kato N, Matsumiya Y, et al. Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol 1999; 37:3062-4.
19. Mirmonsef P, Spear GT. The barrier to HIV transmission provided by genital tract Lactobacillus colonization. Am J Reprod Immunol 2014; 71:531-6.
20. Macklaim JM, Fernandes AD, Di Bella JM, et al. Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 2013; 1:12.
21. Spear GT, French AL, Gilbert D, et al. Human alpha-Amylase present in lower-genital-Tract mucosal fluid processes glycogen to support vaginal colonization by Lactobacillus. J Infect Dis 2014.
22. Petricevic L, Domig KJ, Nierscher JFJ, et al. Characterisation of the vaginal Lactobacillus microbiota associated with preterm delivery. Sci Rep 2014; 4:5136.
23. Romero R, Hassan SS, Gajer P, et al. The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term. Microbiome 2014; 2:18.
24. Hansen LK, Becher N, Bastholm S, et al. The cervical mucus plug inhibits, but does not block, the passage of ascending bacteria from the vagina during pregnancy. Acta Obstet Gynecol Scand 2014; 93:102-8.
25. Kunz G, Bell D, Huppert P, et al. Oxytocin-A stimulator of directed sperm transport in humans. Reprod Biomed Online 2007; 14:32-9.
26. Kunz G, Leyendecker G. Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. Reprod Biomed Online 2002; 4(suppl 3):5-9.
27. Klebanoff SJ, Hillier SL, Eschenbach DA, et al. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991; 164:94-100.
28. OHanlon DE, Lanier BR, Moench TR, et al. Cervicovaginal fluid and semen block the microbicidal activity of hydrogen peroxide produced by vaginal lactobacilli. BMC Infect Dis 2010; 10:120.
29. Aldunate M, Tyssen D, Johnson A, et al. Vaginal concentrations of lactic acid potently inactivate HIV. J Antimicrob Chemother 2013; 68: 2015-25.
30. Olmsted SS, Khanna KV, Ng EM, et al. Low pH immobilizes and kills human leukocytes and prevents transmission of cell-Associated HIV in a mouse model. BMC Infect Dis 2005; 5:79.
31. Khanna KV, Whaley KJ, Zetilin L, et al. Vaginal transmission of cell-Associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 2002; 109:205-11.
32. Alakomi HL, Skytta E, Saarela M, et al. Lactic acid permeabilizes gramnegative bacteria by disrupting the outer membrane. Appl Environ Microbiol 2000; 66:2001-5.
33. Pixley FJ. Macrophage migration and its regulation by CSF-1. Int J Cell Biol 2012; 2012:501962.
34. Lai SK, Hida K, Shukair S, et al. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 2009; 83:11196-200.
35. Carias AM, McCoombe S, McRavenM, et al. Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol 2013; 87:11388-400.
36. Masters WH, Johnson VE. Human sexual response. Boston: Little Brown & Company, 1966; 93.
37. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-Age women. Proc Natl Acad Sci U S A 2011; 108(suppl 1):4680-7.
38. Arpaia N, Rudensky AY. Microbial metabolites control gut inflammatory responses. Proc Natl Acad Sci U S A 2014; 111:2058-9.
39. Mossop H, Linhares IM, Bonglovanni AM, et al. Influence of lactic acid on endogenous and viral RNA-induced immune mediator production by vaginal epithelial cells. Obstet Gynecol 2011; 118:840-6.
40. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, et al. High levels of tumor necrosis factor-Alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis 2000; 182:467-73.
41. Hedges SR, Barrientes F, Desmond RA, et al. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis 2006; 193:556-62.
42. Brotman RM, Bradford LL, Conrad M, et al. Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-Age women. Sex Transm Dis 2012; 39:807-12.
43. Masese L, Baeten JM, Richardson BA, et al. Incident herpes simplex virus type 2 infection increases the risk of subsequent episodes of bacterial vaginosis. J Infect Dis 2014; 209:1023-7.
44. Allsworth JE, Lewis VA, Peipert JF. Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Sex Transm Dis 2008; 35:791-6.
45. Cherpes TL, Meyn LA, Krohn MA, et al. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003; 30:405-10.
46. Corey L, Wald A, Davis LG. Subclinical shedding of HSV: its potential for reduction by antiviral therapy. Adv Exp Med Biol 1996; 394:11-6.
47. Des Jarlais DC, Arasteh K, McKnight C, et al. HSV-2 infection as a cause of female/male and racial/ethnic disparities in HIV infection. PLoS One 2013; 8:e66874.
48. Dickerson MC, Johnston J, Delea TE, et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996; 23:429-40.
49. Quinn TC, Cannon RO, Glasser D, et al. The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. Arch Intern Med 1990; 150:1297-302.
50. McClelland RS, Sangare L, Hassan WM, et al. Infection with trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698-702.
51. Brotman RM, Klebanoff MA, Nansel TR, et al. Bacterial vaginosis assessed by Gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis 2010; 202:1907-15.
52. Houlihan CF, Larke NL, Watson-Jones D, et al. Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-Analysis. AIDS 2012; 26:2211-22.
53. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 2001; 184:418-28.
54. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109:114-20.
55. Sewankambo N, Gray RH, Wawer MJ, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997; 350:546-50.
56. Ravel J, Brotman RM, Gajer P, et al. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 2013; 1:29.
57. Brotman RM, Ravel J, Cone RA, et al. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010; 86:297-302.
58. van de Wijgert JH, Morrison CS, Cornelisse PG, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr 2008; 48:203-10.
59. Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIVacquisition: A meta-Analysis of published studies. AIDS 2008; 22:1493-501.